Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. (NASDAQ: CYRX) on March 11, 2022. The filing reports a material corporate event authorized by the Board of Directors on the same date.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The report focuses exclusively on the authorization of a capital allocation program.
Material Changes
The primary material change reported is the initiation of a new share repurchase program. The Board authorized the purchase of up to $100,000,000 of the company's common stock and/or convertible senior notes. The program is scheduled to remain in effect through December 31, 2025.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on operational outlook, or specific risk factors beyond the standard legal disclaimers regarding the non-filing status of the attached press release for Section 18 liability purposes.
Investor Verification Checklist
- Verify the total authorization amount of $100,000,000 for the repurchase program.
- Confirm the program expiration date of December 31, 2025.
- Note that the program includes the option to repurchase both common stock and convertible senior notes.
- Review the attached Exhibit 99.1 (Press Release) for any additional terms regarding execution methods or timing.